{"title":"Influence of Linker Molecules on the Biodistribution Characteristics of <sup>99m</sup>Tc-labeled Mannose Derivatives with an Isocyanide-Coordinated Group.","authors":"Guangxing Yin, Yuhao Jiang, Junhong Feng, Qing Ruan, Qianna Wang, Peiwen Han, Junbo Zhang","doi":"10.1021/acsptsci.4c00657","DOIUrl":null,"url":null,"abstract":"<p><p>A hallmark of cancer cells is their increased glucose demand, which is mediated by glucose transporters (GLUTs). Mannose is imported into cells via GLUTs, thereby prompting the selection of mannose as the targeting molecule for designing radioactive derivatives for tumor imaging. In this study, five <sup>99m</sup>Tc-labeled mannose derivatives were prepared and evaluated <i>in vitro</i> and <i>in vivo</i>. The derivatives were conjugated with an isonitrile group and different linkers, including (CH<sub>2</sub>)<sub>5</sub>-<sub>D</sub>pro, (CH<sub>2</sub>)<sub>6</sub>-<sub>D</sub>pro, (CH<sub>2</sub>)<sub>7</sub>-<sub>D</sub>pro, (CH<sub>2</sub>)<sub>5</sub>-<sub>L</sub>pro, and (CH<sub>2</sub>)<sub>6</sub>-<sub>L</sub>pro. All five radioactive compounds exhibited hydrophilicity and <i>in vitro</i> stability. A comparative biodistribution study demonstrated that probes modified with <sub>D</sub>-proline exhibited greater uptake in tumors than those modified with <sub>L</sub>-proline. [<sup>99m</sup>Tc]Tc-<b>L1</b> exhibited the highest accumulation in the tumor and the most favorable tumor-to-nontarget ratios. SPECT/CT imaging results of [<sup>99m</sup>Tc]Tc-<b>L1</b> demonstrated clear accumulation and visualization at the tumor site. Blocking studies in cells and mice bearing S180 tumors revealed that [<sup>99m</sup>Tc]Tc-<b>L1</b> was transported into cancer cells via a GLUT-mediated mechanism. These findings suggest that [<sup>99m</sup>Tc]Tc-<b>L1</b> is a promising probe for SPECT tumor imaging and that linker molecules significantly affect biodistribution characteristics.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"8 2","pages":"566-577"},"PeriodicalIF":4.9000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acsptsci.4c00657","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/14 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
A hallmark of cancer cells is their increased glucose demand, which is mediated by glucose transporters (GLUTs). Mannose is imported into cells via GLUTs, thereby prompting the selection of mannose as the targeting molecule for designing radioactive derivatives for tumor imaging. In this study, five 99mTc-labeled mannose derivatives were prepared and evaluated in vitro and in vivo. The derivatives were conjugated with an isonitrile group and different linkers, including (CH2)5-Dpro, (CH2)6-Dpro, (CH2)7-Dpro, (CH2)5-Lpro, and (CH2)6-Lpro. All five radioactive compounds exhibited hydrophilicity and in vitro stability. A comparative biodistribution study demonstrated that probes modified with D-proline exhibited greater uptake in tumors than those modified with L-proline. [99mTc]Tc-L1 exhibited the highest accumulation in the tumor and the most favorable tumor-to-nontarget ratios. SPECT/CT imaging results of [99mTc]Tc-L1 demonstrated clear accumulation and visualization at the tumor site. Blocking studies in cells and mice bearing S180 tumors revealed that [99mTc]Tc-L1 was transported into cancer cells via a GLUT-mediated mechanism. These findings suggest that [99mTc]Tc-L1 is a promising probe for SPECT tumor imaging and that linker molecules significantly affect biodistribution characteristics.
期刊介绍:
ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.
ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.
Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.